| The Medtronic Endeavor III Drug Eluting Coronary Stent System Clinical Trial (NCT00217256) | Medtronic Vascular | 2004-02-01 |
| Effect of an Educational Intervention on Cardiac Patients' Participation Rate in Cardiac Rehabilitation Programs (NCT00356863) | Sheba Medical Center | 2004-02-01 |
| Efficacy and Safety Study of Binodenoson in Assessing Cardiac Ischemia (NCT00944294) | Pfizer | 2004-02-01 |
| TAXUS ARRIVE: TAXUS Peri-Approval Registry: A Multi-Center Safety Surveillance Program (NCT00569491) | Boston Scientific Corporation | 2004-02-01 |
| Diabetes Drug Eluting Sirolimus Stent Experience in Restenosis Trial (NCT00497172) | Cordis US Corp. | 2004-01-01 |
| The Study to Compare Cypher Versus Cypher Select in Treating Cornary Artery Lesions. (NCT00232791) | Cordis US Corp. | 2004-01-01 |
| Direct Comparison of 2D Cardiac PET With 3D Cardiac PET (NCT01993303) | Cardiovascular Imaging Technologies | 2004-01-01 |
| The Study of the Crushing Technique Application Using SES in Coronary Bifurcations. (NCT00749424) | Cordis US Corp. | 2004-01-01 |
| Tissue-Type Plasminogen Activator (t-PA) Release Predicts Major Adverse Cardiac Events (MACE) in Patients With Non-critical Coronary Artery Disease (NCT00868855) | Vanderbilt University | 2003-12-01 |
| SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent System (NCT00180453) | Abbott Medical Devices | 2003-12-01 |
| Phase 3 Safety and Imaging Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing Coronary Angiography (NCT00156845) | Acusphere | 2003-12-01 |
| Phase 3 Imaging and Safety Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing SPECT Imaging (NCT00156793) | Acusphere | 2003-12-01 |
| Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI (NCT00166179) | Emory University | 2003-11-01 |
| Intermittent Cold Blood vs Crystalloid Cardioplegia in Aortic Valve Surgery (NCT00257777) | Oslo University Hospital | 2003-11-01 |
| ADVANCE MPI 1: Study of Regadenoson Versus Adenoscan® in Patients Undergoing Myocardial Perfusion Imaging (MPI) (NCT00208299) | Gilead Sciences | 2003-10-01 |
| V-Flex Plus PTX Drug Eluting Coronary Stent (NCT00225693) | Cook Group Incorporated | 2003-10-01 |
| EArly Discharge After Transradial Stenting of CoronarY Arteries: The EASY Study (NCT00169819) | Laval University | 2003-10-01 |
| Evaluation of Sirolimus-Eluting, Heparin-Coated CoCr Stent in the Treatment of de Novo Coronary Artery Lesions in Small Vessels(EVOLUTION) (NCT00233779) | Cordis US Corp. | 2003-10-01 |
| The Study to Assess AMI Treated With Balloon Angioplasty. (NCT00232830) | Cordis US Corp. | 2003-10-01 |
| The Study of Relationship of Plasma Concentrations of Folic Acid, Vitamin B and Homocysteine With Carotid Atherosclerosis and Endothelium-Dependent Vasodilatation of Geriatric and Young Patients in the Ambulatory Care Department of NTUH (NCT00172250) | National Taiwan University Hospital | 2003-09-01 |
| RRISC Study: Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent. (NCT00263263) | Antwerp Cardiovascular Institute Middelheim | 2003-09-01 |
| Enoxaparin Versus Unfractionated Heparin in PCI (NCT00439855) | Triemli Hospital | 2003-09-01 |
| The Effects of Consumption of Pomegranate Juice on Carotid Intima-Media Thickness (NCT00728299) | Radiant Research | 2003-09-01 |
| Study of the 4.0mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions (NCT00232752) | Cordis US Corp. | 2003-09-01 |
| Full-dose Atorvastatin After Acute Coronary Syndrome (ACS) in Non-revascularisable Coronary Artery Disease (NCT01187992) | San Filippo Neri General Hospital | 2003-09-01 |
| Trial to Assess Chelation Therapy (TACT) (NCT00044213) | Mt. Sinai Medical Center, Miami | 2003-09-01 |
| Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions (NCT00232739) | Cordis US Corp. | 2003-09-01 |
| Multicenter Myocardial Viability Trial (NCT00661232) | CHI St. Luke's Health, Texas | 2003-08-11 |
| A Phase 1b Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis (NCT00244647) | Sarepta Therapeutics, Inc. | 2003-08-01 |
| Percutaneous Coronary Intervention (PCI) With Drug-Eluting Stents (DES) Versus Coronary Artery Bypass Graft (CABG) for Patients With Significant Left Main Stenosis (NCT00176397) | University of Leipzig | 2003-08-01 |
| CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS) (NCT00245401) | Cordis US Corp. | 2003-08-01 |
| The REALITY Study - Head-to-Head Comparison Between Cypher and Taxus (NCT00235092) | Cordis US Corp. | 2003-08-01 |
| Coronary Stenting and Coronary Bypass Grafting at the Same Time in a Specialty Built Operating Room (NCT00366015) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2003-07-29 |
| PTRG-DES Consortium (NCT04734028) | Gyeongsang National University Hospital | 2003-07-09 |
| Comparison Between Pioglitazone and SES With type2 DM (NCT00482183) | Showa University | 2003-07-01 |
| Sulfasalazine and Endothelial Function (NCT00554203) | Boston University | 2003-07-01 |
| A Study of Gadodiamide Injection in Myocardial Perfusion Magnetic Resonance Imaging (NCT00977093) | Amersham Buchler, GmbH & Co KG | 2003-07-01 |
| The ENDEAVOR II Clinical Trial: The Medtronic Endeavor Drug Eluting Coronary Stent System in Coronary Artery Lesions (NCT00614848) | Medtronic Vascular | 2003-06-01 |
| COroNary CT Angiography Evaluation For Clinical Outcomes: An InteRnational Multicenter Registry (CONFIRM) (NCT01443637) | Weill Medical College of Cornell University | 2003-06-01 |
| ARISE - Aggressive Reduction of Inflammation Stops Events (NCT00066898) | AtheroGenics | 2003-06-01 |
| Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With Primary Hypercholesterolemia and Coronary Heart Disease (P03396) (NCT00650689) | Organon and Co | 2003-05-01 |
| Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions (NCT00233714) | Cordis US Corp. | 2003-05-01 |
| Cost-Effectiveness Study in the Reduction of Coronary Restenosis With Sirolimus-Eluting Stents (NCT00627900) | Charite University, Berlin, Germany | 2003-04-01 |
| Effect of Clopidogrel Loading and Risk of PCI (NCT00457236) | University Heart Center Freiburg - Bad Krozingen | 2003-03-01 |
| Short-Term Exposure to Lipophilic Anti-proliferative Drugs Delivered by Angiographic Contrast Media (NCT01140204) | University Hospital, Saarland | 2003-03-01 |
| The Arterial Revascularization Therapies Study Part II. (NCT00235170) | Cordis US Corp. | 2003-02-01 |
| MYOHEART™ (Myogenesis Heart Efficiency and Regeneration Trial) (NCT00054678) | Bioheart, Inc. | 2003-02-01 |
| Family Atherosclerosis Counseling and Testing Project (NCT00387595) | University of British Columbia | 2003-02-01 |
| Radial Artery Versus Saphenous Vein Grafts in Coronary Artery Bypass Surgery (NCT00054847) | US Department of Veterans Affairs | 2003-02-01 |
| Sirolimus-Eluting Stent Versus Standard Stent in Diabetic (NCT00755443) | Hospital San Carlos, Madrid | 2003-02-01 |
| Sirolimus-Eluting Stents for Chronic Total Coronary Occlusions (NCT00258596) | R&D Cardiologie | 2003-01-01 |
| Troponin I and T and Adverse Outcomes in Patients With and Without Diabetes Mellitus After Coronary Intervention (NCT03627455) | Wilhelminenspital Vienna | 2003-01-01 |
| Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry) (NCT01788592) | Seung-Jung Park | 2003-01-01 |
| MIDCAB Versus DES in Proximal LAD Lesions (NCT00299429) | University of Leipzig | 2003-01-01 |
| Programme to Optimise Risk Factors in Patients Waiting for Coronary Artery Bypass Surgery (NCT00124371) | Royal Brompton & Harefield NHS Foundation Trust | 2003-01-01 |
| Anti Ischemic Effects of Abciximab in Angioplasty and Stenting Patients (NCT00379418) | Emory University | 2003-01-01 |
| A Study of the Cypher SES to Treat Restenotic Native Coronary Artery Lesions. (NCT00232856) | Cordis US Corp. | 2002-12-01 |
| The Prospective Segeberg Registry for Rotational Atherectomy in Coronary Lesion/s (NCT04011527) | Segeberger Kliniken GmbH | 2002-11-25 |
| Risk Markers in the Acute Coronary Syndromes (NCT00521976) | Helse Stavanger HF | 2002-11-01 |
| The CYPHER™ Stent Study in Patients With Small de Novo Coronary Artery Lesions. (NCT00235066) | Cordis US Corp. | 2002-11-01 |
| Effect of Acute Statin Treatment in Patients Undergoing Percutaneous Coronary Intervention (NCT00588471) | Mayo Clinic | 2002-11-01 |
| A Study of Diabetic Patients With De Novo Native Coronary Artery Lesions (NCT00495898) | Cordis US Corp. | 2002-11-01 |
| Evaluation of an Ayurvedic Herbal Compound Compared to Vitamins C+E and Placebo on Vascular Function in High-Risk Subjects (NCT07206901) | Maharishi International University | 2002-10-14 |
| Stenting With or Without Coating Compared With Angioplasty in Non-benestent Disease (NCT00192881) | Rigshospitalet, Denmark | 2002-10-01 |
| Evaluation of Two Reduced Sirolimus Doses in Treatment of de Novo Coronary Artery Lesions (REDOX) (NCT00233766) | Cordis US Corp. | 2002-09-01 |
| Persantine: Variation in Response Trial (NCT00763009) | UConn Health | 2002-09-01 |
| Prevention of Instent Renarrowing With Aggressive Glucose Lowering With Pioglitazone in Diabetic Patients (NCT00819325) | Queen Elizabeth II Health Sciences Centre | 2002-08-01 |
| Training at Different Intensities in Coronary Artery Disease -Effects on Myocardial Function (NCT00201591) | Norwegian University of Science and Technology | 2002-08-01 |
| Stem Cell Mobilization to Treat Chest Pain and Shortness of Breath in Patients With Coronary Artery Disease (NCT00043628) | National Heart, Lung, and Blood Institute (NHLBI) | 2002-08-01 |
| Effect of Creatine and L-Arginine on Endothelial Function (NCT00551434) | Boston University | 2002-08-01 |
| Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease 007 (NCT00595673) | Point Biomedical | 2002-07-01 |
| Prevention of Autogenous Vein Graft Failure in Coronary Artery Bypass Procedures (NCT00042081) | Anesiva, Inc. | 2002-07-01 |
| Substrate Modification in Stable Ventricular Tachycardia in Addition to Implantable Cardioverter Defibrillator (ICD) Therapy (NCT00919373) | Abbott Medical Devices | 2002-07-01 |
| Multicentre Radial Artery Patency Study: Results of Patency Beyond 5 Years After Coronary Artery Bypass Surgery (NCT00187356) | Sunnybrook Health Sciences Centre | 2002-07-01 |
| Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease (NCT00595244) | Point Biomedical | 2002-07-01 |
| Benefit of Elevation of HDL-C on Cardiovascular Outcomes in Women (NCT00590629) | Cedars-Sinai Medical Center | 2002-06-01 |
| The BRIDGE Registry: Safety and Efficacy Registry of Bx Cypher Stent (NCT00232804) | Cordis US Corp. | 2002-06-01 |
| A Randomized, Double-blind Study to Assess Paclitaxel-eluting Stents in Treatment of Longer Lesions (NCT00297804) | Boston Scientific Corporation | 2002-05-01 |
| The Role of Atorvastatin on Monocyte Function in Patients With Coronary Artery Disease and Hypercholesterolemia (NCT00329069) | University of Ulm | 2002-05-01 |
| Symptom Management Intervention in Elderly Coronary Artery Bypass Patients (NCT00572988) | University of Nebraska | 2002-05-01 |
| Double-Blind Comparison of Combined General-Spinal Anesthesia to General Anesthesia for Coronary Artery Surgery (NCT00242697) | University of Calgary | 2002-04-01 |
| In Stent ELUTES Study (NCT00225680) | Cook Group Incorporated | 2002-04-01 |
| Distal Protection Combined With PTCA in AMI Patients (NCT00264030) | Cordis US Corp. | 2002-03-01 |
| Chlamydia and Mycoplasma in Coronary Artery Disease (NCT00561028) | Hospital de Base | 2002-03-01 |
| TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent (NCT00292474) | Boston Scientific Corporation | 2002-03-01 |
| Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in a Compassionate Use Registry (SECURE) (NCT00231244) | Cordis US Corp. | 2002-03-01 |
| Familiarization and Safety Study of PB127 Ultrasound Contrast Agent (NCT00594698) | Point Biomedical | 2002-02-01 |
| Vision II: Evaluation of GALILEO Intravascular Radiotherapy System (NCT00180583) | Abbott Medical Devices | 2002-02-01 |
| Portuguese Registry on Interventional Cardiology (NCT01867801) | Portuguese Society of Cardiology | 2002-01-01 |
| Cell Therapy for Coronary Heart Disease (NCT00289822) | Johann Wolfgang Goethe University Hospital | 2002-01-01 |
| Bone Marrow Transfer to Enhance ST-Elevation Infarct Regeneration (NCT00224536) | Hannover Medical School | 2002-01-01 |
| Evaluation of Effects of Rosuvastatin 40mg on Myocardial Ischemia in Subjects With Coronary Artery Disease (NCT00657527) | AstraZeneca | 2001-12-01 |
| A Safety Study of ABI-007 for In-Stent Restenosis (NCT00093223) | Celgene | 2001-09-01 |
| Long-term Outcomes of Patients After Coronary Bifurcation Stenting (NCT00325884) | VA Boston Healthcare System | 2001-08-01 |
| A Randomized, Double-Blind, Controlled Study of the Safety and Performance of the NIRx™ Paclitaxel-Coated Conformer Coronary Stent (NCT00299026) | Boston Scientific Corporation | 2001-06-01 |
| Prophylactic Effect of Nifedipine on Further Decline in Renal Function in Patients Undergoing Open-Heart Surgery (NCT00244530) | University of Oslo School of Pharmacy | 2001-06-01 |
| A Study of the Cypher Sirolimus-Eluting Stent to Treat Bifurcation Lesions. (NCT00234455) | Cordis US Corp. | 2001-06-01 |
| Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication (NCT00715273) | University of Washington | 2001-05-01 |
| The Viability-Guided Angioplasty After Acute Myocardial Infarction-Trial (The VIAMI-Trial) (NCT00149591) | Netherlands Heart Foundation | 2001-04-01 |
| The Study of the BX VELOCITY Stent In Patients With De Novo Coronary Artery Lesions. (NCT00235144) | Cordis US Corp. | 2001-03-01 |